{"transactions":[{"id":832727,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56927,"kind":"person","name":"Brown Martin S JR","position":1,"cik":"0001362521","reported_name":"Brown Martin S JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-20T21:24:05.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":1800,"price":2.8,"value":5040.0,"ownership":{"direct":true},"balance_after":10300,"source":{"system":"sec-edgar","filing":"0001087294-26-000040","document":"wk-form4_1774041843.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000040/wk-form4_1774041843.xml","form_type":"4"}},{"id":832726,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56926,"kind":"person","name":"Galante Joseph C","position":1,"cik":"0001632384","reported_name":"Galante Joseph C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-20T21:23:43.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":1800,"price":2.8,"value":5040.0,"ownership":{"direct":true},"balance_after":63656,"source":{"system":"sec-edgar","filing":"0001632384-26-000002","document":"wk-form4_1774041820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000163238426000002/wk-form4_1774041820.xml","form_type":"4"}},{"id":832725,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-20T21:22:41.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":1800,"price":2.8,"value":5040.0,"ownership":{"direct":true},"balance_after":46863,"source":{"system":"sec-edgar","filing":"0001087294-26-000039","document":"wk-form4_1774041759.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000039/wk-form4_1774041759.xml","form_type":"4"}},{"id":832724,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-20T21:22:02.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":2.8,"value":11200.0,"ownership":{"direct":true},"balance_after":302338,"source":{"system":"sec-edgar","filing":"0001087294-26-000037","document":"wk-form4_1774041719.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000037/wk-form4_1774041719.xml","form_type":"4"}},{"id":832723,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-20T21:22:02.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":1800,"price":2.8,"value":5040.0,"ownership":{"direct":true},"balance_after":298338,"source":{"system":"sec-edgar","filing":"0001087294-26-000037","document":"wk-form4_1774041719.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000037/wk-form4_1774041719.xml","form_type":"4"}},{"id":832722,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56923,"kind":"person","name":"Young Caroline","position":1,"cik":"0001684087","reported_name":"Young Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-20T21:21:41.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":1800,"price":2.8,"value":5040.0,"ownership":{"direct":true},"balance_after":35109,"source":{"system":"sec-edgar","filing":"0001087294-26-000036","document":"wk-form4_1774041699.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000036/wk-form4_1774041699.xml","form_type":"4"}},{"id":832721,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56922,"kind":"person","name":"Anthony Todd M.","position":1,"cik":"0001969711","reported_name":"Anthony Todd M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Pres Organizational Dev"}}],"security":"Options (right to buy)","published_at":"2026-03-20T21:21:16.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":2.8,"value":8400.0,"ownership":{"direct":true},"balance_after":21000,"derivative":{"exercise_price":2.8,"exercise_date":"2030-03-18","expiration_date":"2036-03-18","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001087294-26-000035","document":"wk-form4_1774041673.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000035/wk-form4_1774041673.xml","form_type":"4"}},{"id":832720,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56921,"kind":"person","name":"Bitterman Chris T.","position":1,"cik":"0001969681","reported_name":"Bitterman Chris T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Pres Sales & Marketing"}}],"security":"Options (right to buy)","published_at":"2026-03-20T21:20:52.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":2.8,"value":8400.0,"ownership":{"direct":true},"balance_after":19000,"derivative":{"exercise_price":2.8,"exercise_date":"2030-03-18","expiration_date":"2036-03-16","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001087294-26-000034","document":"wk-form4_1774041649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000034/wk-form4_1774041649.xml","form_type":"4"}},{"id":832719,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56920,"kind":"person","name":"Hamm John M.","position":1,"cik":"0001870439","reported_name":"Hamm John M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Chief Financial Officer"}}],"security":"Options (right to buy)","published_at":"2026-03-20T21:20:31.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":2.8,"value":8400.0,"ownership":{"direct":true},"balance_after":18250,"derivative":{"exercise_price":2.8,"exercise_date":"2030-03-18","expiration_date":"2036-03-18","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001087294-26-000033","document":"wk-form4_1774041628.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000033/wk-form4_1774041628.xml","form_type":"4"}},{"id":832718,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56919,"kind":"person","name":"Herman James L","position":1,"cik":"0001572342","reported_name":"Herman James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Compliance Office"}}],"security":"Options (right to buy)","published_at":"2026-03-20T21:20:05.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":2.8,"value":7000.0,"ownership":{"direct":true},"balance_after":21000,"derivative":{"exercise_price":2.8,"exercise_date":"2030-03-18","expiration_date":"2036-03-18","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001572342-26-000002","document":"wk-form4_1774041602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000157234226000002/wk-form4_1774041602.xml","form_type":"4"}},{"id":832717,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Options (right to buy)","published_at":"2026-03-20T21:19:28.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":2.8,"value":280000.0,"ownership":{"direct":true},"balance_after":568000,"derivative":{"exercise_price":2.8,"exercise_date":"2030-03-18","expiration_date":"2036-03-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001087294-26-000032","document":"wk-form4_1774041566.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000032/wk-form4_1774041566.xml","form_type":"4"}},{"id":835778,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-03-18T21:30:35.000Z","date":"2026-03-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":5845,"price":3.06,"value":17885.7,"ownership":{"direct":true},"balance_after":5695310,"source":{"system":"sec-edgar","filing":"0001628280-26-019514","document":"wk-form4_1773869429.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828026019514/wk-form4_1773869429.xml","form_type":"4"}},{"id":948180,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56923,"kind":"person","name":"Young Caroline","position":1,"cik":"0001684087","reported_name":"Young Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:05:10.000Z","date":"2025-12-31","kind":"other","planned":true,"acquired":true,"shares":5,"price":3.91,"value":19.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":33309,"source":{"system":"sec-edgar","filing":"0001087294-26-000008","document":"wk-form4_1767737104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000008/wk-form4_1767737104.xml","form_type":"4"}},{"id":948179,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56923,"kind":"person","name":"Young Caroline","position":1,"cik":"0001684087","reported_name":"Young Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:05:10.000Z","date":"2025-12-30","kind":"other","planned":true,"acquired":true,"shares":2,"price":3.94,"value":7.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":33304,"source":{"system":"sec-edgar","filing":"0001087294-26-000008","document":"wk-form4_1767737104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000008/wk-form4_1767737104.xml","form_type":"4"}},{"id":948178,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56923,"kind":"person","name":"Young Caroline","position":1,"cik":"0001684087","reported_name":"Young Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:05:10.000Z","date":"2025-12-29","kind":"other","planned":true,"acquired":true,"shares":2,"price":4.01,"value":8.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":33302,"source":{"system":"sec-edgar","filing":"0001087294-26-000008","document":"wk-form4_1767737104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000008/wk-form4_1767737104.xml","form_type":"4"}},{"id":948177,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56923,"kind":"person","name":"Young Caroline","position":1,"cik":"0001684087","reported_name":"Young Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:05:10.000Z","date":"2025-12-26","kind":"other","planned":true,"acquired":true,"shares":2,"price":4.21,"value":8.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":33300,"source":{"system":"sec-edgar","filing":"0001087294-26-000008","document":"wk-form4_1767737104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000008/wk-form4_1767737104.xml","form_type":"4"}},{"id":948176,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56923,"kind":"person","name":"Young Caroline","position":1,"cik":"0001684087","reported_name":"Young Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:05:10.000Z","date":"2025-12-24","kind":"other","planned":true,"acquired":true,"shares":2,"price":4.26,"value":8.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":33298,"source":{"system":"sec-edgar","filing":"0001087294-26-000008","document":"wk-form4_1767737104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000008/wk-form4_1767737104.xml","form_type":"4"}},{"id":948175,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56923,"kind":"person","name":"Young Caroline","position":1,"cik":"0001684087","reported_name":"Young Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:05:10.000Z","date":"2025-12-23","kind":"other","planned":true,"acquired":true,"shares":2,"price":4.13,"value":8.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":33296,"source":{"system":"sec-edgar","filing":"0001087294-26-000008","document":"wk-form4_1767737104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000008/wk-form4_1767737104.xml","form_type":"4"}},{"id":948174,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56923,"kind":"person","name":"Young Caroline","position":1,"cik":"0001684087","reported_name":"Young Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:05:10.000Z","date":"2025-12-22","kind":"other","planned":true,"acquired":true,"shares":2,"price":4.32,"value":8.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":33294,"source":{"system":"sec-edgar","filing":"0001087294-26-000008","document":"wk-form4_1767737104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000008/wk-form4_1767737104.xml","form_type":"4"}},{"id":948173,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56923,"kind":"person","name":"Young Caroline","position":1,"cik":"0001684087","reported_name":"Young Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:05:10.000Z","date":"2025-12-19","kind":"other","planned":true,"acquired":true,"shares":2,"price":4.19,"value":8.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":33292,"source":{"system":"sec-edgar","filing":"0001087294-26-000008","document":"wk-form4_1767737104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000008/wk-form4_1767737104.xml","form_type":"4"}},{"id":948172,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56923,"kind":"person","name":"Young Caroline","position":1,"cik":"0001684087","reported_name":"Young Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:05:10.000Z","date":"2025-12-18","kind":"other","planned":true,"acquired":true,"shares":3,"price":4.19,"value":12.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":33290,"source":{"system":"sec-edgar","filing":"0001087294-26-000008","document":"wk-form4_1767737104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000008/wk-form4_1767737104.xml","form_type":"4"}},{"id":948171,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56923,"kind":"person","name":"Young Caroline","position":1,"cik":"0001684087","reported_name":"Young Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:05:10.000Z","date":"2025-12-17","kind":"other","planned":true,"acquired":true,"shares":3,"price":3.65,"value":10.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":33287,"source":{"system":"sec-edgar","filing":"0001087294-26-000008","document":"wk-form4_1767737104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000008/wk-form4_1767737104.xml","form_type":"4"}},{"id":948170,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56923,"kind":"person","name":"Young Caroline","position":1,"cik":"0001684087","reported_name":"Young Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:05:10.000Z","date":"2025-12-16","kind":"other","planned":true,"acquired":true,"shares":3,"price":3.27,"value":9.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":33284,"source":{"system":"sec-edgar","filing":"0001087294-26-000008","document":"wk-form4_1767737104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000008/wk-form4_1767737104.xml","form_type":"4"}},{"id":948169,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56923,"kind":"person","name":"Young Caroline","position":1,"cik":"0001684087","reported_name":"Young Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:05:10.000Z","date":"2025-12-15","kind":"other","planned":true,"acquired":true,"shares":3,"price":2.82,"value":8.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":33281,"source":{"system":"sec-edgar","filing":"0001087294-26-000008","document":"wk-form4_1767737104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000008/wk-form4_1767737104.xml","form_type":"4"}},{"id":948168,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56923,"kind":"person","name":"Young Caroline","position":1,"cik":"0001684087","reported_name":"Young Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:05:10.000Z","date":"2025-12-12","kind":"other","planned":true,"acquired":true,"shares":3,"price":2.5,"value":7.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":33278,"source":{"system":"sec-edgar","filing":"0001087294-26-000008","document":"wk-form4_1767737104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000008/wk-form4_1767737104.xml","form_type":"4"}},{"id":948167,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56923,"kind":"person","name":"Young Caroline","position":1,"cik":"0001684087","reported_name":"Young Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:05:10.000Z","date":"2025-12-11","kind":"other","planned":true,"acquired":true,"shares":3,"price":2.56,"value":7.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":33275,"source":{"system":"sec-edgar","filing":"0001087294-26-000008","document":"wk-form4_1767737104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000008/wk-form4_1767737104.xml","form_type":"4"}},{"id":948166,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56923,"kind":"person","name":"Young Caroline","position":1,"cik":"0001684087","reported_name":"Young Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:05:10.000Z","date":"2025-12-10","kind":"other","planned":true,"acquired":true,"shares":3,"price":2.6,"value":7.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":33272,"source":{"system":"sec-edgar","filing":"0001087294-26-000008","document":"wk-form4_1767737104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000008/wk-form4_1767737104.xml","form_type":"4"}},{"id":948165,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56923,"kind":"person","name":"Young Caroline","position":1,"cik":"0001684087","reported_name":"Young Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:05:10.000Z","date":"2025-12-09","kind":"other","planned":true,"acquired":true,"shares":3,"price":2.32,"value":6.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":33269,"source":{"system":"sec-edgar","filing":"0001087294-26-000008","document":"wk-form4_1767737104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000008/wk-form4_1767737104.xml","form_type":"4"}},{"id":948164,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56923,"kind":"person","name":"Young Caroline","position":1,"cik":"0001684087","reported_name":"Young Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:05:10.000Z","date":"2025-12-08","kind":"other","planned":true,"acquired":true,"shares":3,"price":2.4,"value":7.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":33266,"source":{"system":"sec-edgar","filing":"0001087294-26-000008","document":"wk-form4_1767737104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000008/wk-form4_1767737104.xml","form_type":"4"}},{"id":948163,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56923,"kind":"person","name":"Young Caroline","position":1,"cik":"0001684087","reported_name":"Young Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:05:10.000Z","date":"2025-12-05","kind":"other","planned":true,"acquired":true,"shares":4,"price":2.34,"value":9.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":33263,"source":{"system":"sec-edgar","filing":"0001087294-26-000008","document":"wk-form4_1767737104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000008/wk-form4_1767737104.xml","form_type":"4"}},{"id":948162,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56923,"kind":"person","name":"Young Caroline","position":1,"cik":"0001684087","reported_name":"Young Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:05:10.000Z","date":"2025-12-04","kind":"other","planned":true,"acquired":true,"shares":4,"price":2.27,"value":9.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":33259,"source":{"system":"sec-edgar","filing":"0001087294-26-000008","document":"wk-form4_1767737104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000008/wk-form4_1767737104.xml","form_type":"4"}},{"id":948161,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56923,"kind":"person","name":"Young Caroline","position":1,"cik":"0001684087","reported_name":"Young Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:05:10.000Z","date":"2025-12-03","kind":"other","planned":true,"acquired":true,"shares":4,"price":2.25,"value":9.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":33255,"source":{"system":"sec-edgar","filing":"0001087294-26-000008","document":"wk-form4_1767737104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000008/wk-form4_1767737104.xml","form_type":"4"}},{"id":948160,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56923,"kind":"person","name":"Young Caroline","position":1,"cik":"0001684087","reported_name":"Young Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:05:10.000Z","date":"2025-12-02","kind":"other","planned":true,"acquired":true,"shares":4,"price":2.24,"value":8.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":33251,"source":{"system":"sec-edgar","filing":"0001087294-26-000008","document":"wk-form4_1767737104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000008/wk-form4_1767737104.xml","form_type":"4"}},{"id":948159,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56923,"kind":"person","name":"Young Caroline","position":1,"cik":"0001684087","reported_name":"Young Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:05:10.000Z","date":"2025-12-01","kind":"other","planned":true,"acquired":true,"shares":4,"price":2.36,"value":9.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":33247,"source":{"system":"sec-edgar","filing":"0001087294-26-000008","document":"wk-form4_1767737104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000008/wk-form4_1767737104.xml","form_type":"4"}},{"id":948136,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-31","kind":"other","planned":true,"acquired":true,"shares":7,"price":3.91,"value":27.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":45063,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948135,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-30","kind":"other","planned":true,"acquired":true,"shares":8,"price":3.94,"value":31.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":45056,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948134,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-29","kind":"other","planned":true,"acquired":true,"shares":8,"price":4.01,"value":32.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":45048,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948133,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-26","kind":"other","planned":true,"acquired":true,"shares":8,"price":4.21,"value":33.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":45040,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948132,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-24","kind":"other","planned":true,"acquired":true,"shares":8,"price":4.26,"value":34.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":45032,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948131,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-23","kind":"other","planned":true,"acquired":true,"shares":8,"price":4.13,"value":33.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":45024,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948130,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-22","kind":"other","planned":true,"acquired":true,"shares":7,"price":4.32,"value":30.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":45016,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948129,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-19","kind":"other","planned":true,"acquired":true,"shares":8,"price":4.19,"value":33.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":45009,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948128,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-18","kind":"other","planned":true,"acquired":true,"shares":10,"price":4.19,"value":41.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":45001,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948127,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-17","kind":"other","planned":true,"acquired":true,"shares":10,"price":3.65,"value":36.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44991,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948126,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-16","kind":"other","planned":true,"acquired":true,"shares":14,"price":3.27,"value":45.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44981,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948125,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-15","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.82,"value":39.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44967,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948124,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-12","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.5,"value":35.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44953,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948123,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-11","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.56,"value":35.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44939,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948122,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-10","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.6,"value":36.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44925,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948121,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-09","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.32,"value":32.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44911,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948120,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-08","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.4,"value":33.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44897,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948119,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-05","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.34,"value":42.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44883,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948118,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-04","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.27,"value":40.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44865,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948117,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-03","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.25,"value":40.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44847,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948116,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-02","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.24,"value":40.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44829,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948115,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-01","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.36,"value":42.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44811,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948158,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-31","kind":"other","planned":true,"acquired":true,"shares":7,"price":3.91,"value":27.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701155,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948157,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-30","kind":"other","planned":true,"acquired":true,"shares":8,"price":3.94,"value":31.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701148,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948156,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-29","kind":"other","planned":true,"acquired":true,"shares":8,"price":4.01,"value":32.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701140,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948155,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-26","kind":"other","planned":true,"acquired":true,"shares":8,"price":4.21,"value":33.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701132,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948154,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-24","kind":"other","planned":true,"acquired":true,"shares":8,"price":4.26,"value":34.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701124,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948153,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-23","kind":"other","planned":true,"acquired":true,"shares":8,"price":4.13,"value":33.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701116,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948152,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-22","kind":"other","planned":true,"acquired":true,"shares":7,"price":4.32,"value":30.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701108,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948151,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-19","kind":"other","planned":true,"acquired":true,"shares":8,"price":4.19,"value":33.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701101,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948150,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-18","kind":"other","planned":true,"acquired":true,"shares":10,"price":4.19,"value":41.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701093,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948149,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-17","kind":"other","planned":true,"acquired":true,"shares":10,"price":3.65,"value":36.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701083,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948148,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-16","kind":"other","planned":true,"acquired":true,"shares":14,"price":3.27,"value":45.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701073,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948147,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-15","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.82,"value":39.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701059,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948146,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-12","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.5,"value":35.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701045,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948145,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-11","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.56,"value":35.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701031,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948144,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-10","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.6,"value":36.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701017,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948143,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-09","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.32,"value":32.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701003,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948142,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-08","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.4,"value":33.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700989,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948141,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-05","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.34,"value":42.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700975,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948140,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-04","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.27,"value":40.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700957,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948139,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-03","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.25,"value":40.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700939,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948138,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-02","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.24,"value":40.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700921,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948137,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-01","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.36,"value":42.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700903,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948114,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-31","kind":"other","planned":true,"acquired":true,"shares":62,"price":3.91,"value":242.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":296538,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948113,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-30","kind":"other","planned":true,"acquired":true,"shares":54,"price":3.94,"value":212.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":296476,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948112,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-29","kind":"other","planned":true,"acquired":true,"shares":54,"price":4.01,"value":216.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":296422,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948111,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-26","kind":"other","planned":true,"acquired":true,"shares":54,"price":4.21,"value":227.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":296368,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948110,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-24","kind":"other","planned":true,"acquired":true,"shares":54,"price":4.26,"value":230.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":296314,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948109,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-23","kind":"other","planned":true,"acquired":true,"shares":54,"price":4.13,"value":223.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":296260,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948108,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-22","kind":"other","planned":true,"acquired":true,"shares":50,"price":4.32,"value":216.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":296206,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948107,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-19","kind":"other","planned":true,"acquired":true,"shares":52,"price":4.19,"value":217.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":296156,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948106,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-18","kind":"other","planned":true,"acquired":true,"shares":67,"price":4.19,"value":280.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":296104,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948105,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-17","kind":"other","planned":true,"acquired":true,"shares":67,"price":3.65,"value":244.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":296037,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948104,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-16","kind":"other","planned":true,"acquired":true,"shares":104,"price":3.27,"value":340.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":295970,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948103,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-15","kind":"other","planned":true,"acquired":true,"shares":104,"price":2.82,"value":293.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":295866,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948102,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-12","kind":"other","planned":true,"acquired":true,"shares":104,"price":2.5,"value":260.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":295762,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948101,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-11","kind":"other","planned":true,"acquired":true,"shares":104,"price":2.56,"value":266.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":295658,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948100,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-10","kind":"other","planned":true,"acquired":true,"shares":104,"price":2.6,"value":270.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":295554,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948099,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-09","kind":"other","planned":true,"acquired":true,"shares":104,"price":2.32,"value":241.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":295450,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948098,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-08","kind":"other","planned":true,"acquired":true,"shares":104,"price":2.4,"value":249.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":295346,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948097,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-05","kind":"other","planned":true,"acquired":true,"shares":124,"price":2.34,"value":290.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":295242,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948096,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-04","kind":"other","planned":true,"acquired":true,"shares":124,"price":2.27,"value":281.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":295118,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948095,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-03","kind":"other","planned":true,"acquired":true,"shares":124,"price":2.25,"value":279.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":294994,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948094,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-02","kind":"other","planned":true,"acquired":true,"shares":124,"price":2.24,"value":277.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":294870,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}},{"id":948093,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56924,"kind":"person","name":"Krogulski Kenneth","position":1,"cik":"0001695580","reported_name":"Krogulski Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:03:12.000Z","date":"2025-12-01","kind":"other","planned":true,"acquired":true,"shares":124,"price":2.36,"value":292.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":294746,"source":{"system":"sec-edgar","filing":"0001087294-26-000002","document":"wk-form4_1767736989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000002/wk-form4_1767736989.xml","form_type":"4"}}],"next_cursor":"2026-01-06T22:03:12.000000Z,948093"}